HIGHLIGHTS
- who: Relapse-Remitting Multiple Sclerosis et al. from the Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China, Department of Neurology, Baoding No have published the research: Label-free Quantitative Proteomic Analysis of Cerebrospinal Fluid and Serum in Patients With Relapse-Remitting Multiple Sclerosis, in the Journal: (JOURNAL)
- what: This study compared two separate cohorts of cases with healthy controls and patients with other neurological disorders (Huang et_al, 2020). In this study, blood and CSF samples were collected before the treatment such as the hormone therapy and immunoglobulin therapy. The authors investigate the CSF . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.